Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Calquence

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 24,515Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Calquence

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Calquence

    Acalabrutinib

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 522

    2019 Revenue in Millions : 164

    Growth (%) : 218

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 1,238

    2020 Revenue in Millions : 522

    Growth (%) : 137

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 2,057

    2021 Revenue in Millions : 1,238

    Growth (%) : 66

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 2,514

    2022 Revenue in Millions : 2,057

    Growth (%) : 22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 3,129

    2023 Revenue in Millions : 2,514

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2017 Revenue in Millions : 3

    2016 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 62

    2017 Revenue in Millions : 3

    Growth (%) : 1967%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Calquence

    Acalabrutinib

    arrow
    Biotech Showcase
    Not Confirmed

    Brand Name : Calquence

    United Kingdom
    arrow
    Biotech Showcase
    Not Confirmed

    AstraZeneca

    Acalabrutinib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 164

    2018 Revenue in Millions : 62

    Growth (%) : 165

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.